Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.

An update of genetic basis of PCOS pathogenesis

Open access
Crespo, Raiane P., Bachega, Tania A. S. S., Mendonça, Berenice B., Gomes, Larissa G. · 2018 · Archives of Endocrinology and Metabolism

Abstract

Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder that affects 5-20% of reproductive age women. PCOS clinical symptoms include hirsutism, menstrual dysfunction, infertility, obesity and metabolic syndrome. There is a wide heterogeneity in clinical manifestations and metabolic complications. The pathogenesis of PCOS is not fully elucidated, but four aspects seem to contribute to the syndrome to different degrees: increased ovarian and/or adrenal androgen secretion, partial folliculogenesis arrest, insulin resistance and neuroendocrine axis dysfunction. A definitive etiology remains to be elucidated, but PCOS has a strong heritable component indicated by familial clustering and twin studies. Genome Wide Association Studies (GWAS) have identified several new risk loci and candidate genes for PCOS. Despite these findings, the association studies have explained less than 10% of heritability. Therefore, we could speculate that different phenotypes and subphenotypes are caused by rare private genetic variants. Modern genetic studies, such as whole exome and genome sequencing, will help to clarify the contribution of these rare genetic variants on different PCOS phenotypes. Arch Endocrinol Metab. 2018;62(3):352-61.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.20945/2359-3997000000049

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Ovarian steroidogenesis. (A) Normal ovarian steroid synthesis. (B) PCOS ovarian steroid synthesis. In comparison to normal theca cells, PCOS theca cells show increased expression of LH receptor and increased expression of CYP17A1 gene, leading to enhance of 17α-hydroxylase and 17,20-lyase activity, and amplifying androgen synthesis. Exogenous factors, such as hyperinsulinemia and IGFs are modulatory hormones that can disrupt normal intra-ovarian regulatation of steroidogenesis.
Figure 1 Ovarian steroidogenesis. (A) Normal ovarian steroid synthesis. (B) PCOS ovarian steroid synthesis. In comparison to normal theca cells, PCOS theca cells show increased expression of LH receptor and increased expression of CYP17A1 gene, leading to enhance of 17α-hydroxylase and 17,20-lyase activity, and amplifying androgen synthesis. Exogenous factors, such as hyperinsulinemia and IGFs are modulatory hormones that can disrupt normal intra-ovarian regulatation of steroidogenesis.CC BY · PubMed Central
Figure 2 Role of AMH in folliculogenesis. AMH has an inibitory effect on initial recruitment of primary follicles, on FSH-dependent follicular maturation and selection of dominant follicle, and on FSH-induced aromatase expression on granulosa cells, reducing the conversion of testosterone into estradiol. Higher AMH levels in PCOS patients turns the follicles more resistant to FSH action, culminating in inhibition of follicular maturarion and ovulation, and in inhibiton of aromatase expression, and consequently, leading to hyperandrogenism. Adapted from Azziz and cols. 2016 (1).
Figure 2 Role of AMH in folliculogenesis. AMH has an inibitory effect on initial recruitment of primary follicles, on FSH-dependent follicular maturation and selection of dominant follicle, and on FSH-induced aromatase expression on granulosa cells, reducing the conversion of testosterone into estradiol. Higher AMH levels in PCOS patients turns the follicles more resistant to FSH action, culminating in inhibition of follicular maturarion and ovulation, and in inhibiton of aromatase expression, and consequently, leading to hyperandrogenism. Adapted from Azziz and cols. 2016 (1).CC BY · PubMed Central
Figure 3 Schematic components of PCOS pathogenesis. Four main physiologic mechanisms contribute to PCOS pathogenesis: hyperandrogenism (HY), insulin resistance (IR), folliculogenesis dysfunction (FC), and neuroendocrine axis dysfunction (ND). These mechanisms contribute to each phenotype in different degrees. The classical phenotype shows alterations in all four mechanism, being HY and IR the main ones (A). In the ovulatory phenotype, HY and ND predominate and folliculogenesis seems not compromised (B). In contrast, in the normoandrogenic phenotype, FC seems to play the most important role in the pathogenesis, while HY is not present (C).
Figure 3 Schematic components of PCOS pathogenesis. Four main physiologic mechanisms contribute to PCOS pathogenesis: hyperandrogenism (HY), insulin resistance (IR), folliculogenesis dysfunction (FC), and neuroendocrine axis dysfunction (ND). These mechanisms contribute to each phenotype in different degrees. The classical phenotype shows alterations in all four mechanism, being HY and IR the main ones (A). In the ovulatory phenotype, HY and ND predominate and folliculogenesis seems not compromised (B). In contrast, in the normoandrogenic phenotype, FC seems to play the most important role in the pathogenesis, while HY is not present (C).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 1

  1. 3. JK Z. Diagnostic criteria of polycystic ovary syndrome; towards a rational approach. In: Dunaif A, ditor. Polycystic Ovary Syndrome ed. Boston, MA: Blackwell Scientific; 1992.

Cited by

See all 143

Metadata

Authors
Crespo, R. P., Bachega, T. A. S. S., Mendonça, B. B., & Gomes, L. G.
Affiliations
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Venue
Archives of Endocrinology and Metabolism
Published
2018-06
Volume
62
Issue
3
Pages
352-361
ISSN
  • 2359-3997 (ISSN-L)
  • 2359-4292
OpenAlex
W2810280311
Cited by
138
References
65
Citations by year
2026: 4 · 2025: 11 · 2024: 27 · 2023: 19 · 2022: 22 · 2021: 18 · 2020: 24 · 2019: 13
FWCI
2.08
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Archives of Endocrinology and Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
polycystic ovary syndrome, PCOS pathogenesis, genetic basis, heritability, genome-wide association study, candidate genes, rare variants, hyperandrogenism, insulin resistance, folliculogenesis, neuroendocrine dysfunction, PCOS phenotypes, twin studies, familial aggregation
MeSH terms
Female, Humans, Phenotype, Polycystic Ovary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An update of genetic basis of PCOS pathogenesis. https://app.cochat.ai/papers/10.20945/2359-3997000000049
The paper
Crespo, R. P., Bachega, T. A. S. S., Mendonça, B. B., & Gomes, L. G. (2018). An update of genetic basis of PCOS pathogenesis. Archives of Endocrinology and Metabolism. https://doi.org/10.20945/2359-3997000000049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.